Cargando…
Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase
Febrifugine, one of the fifty fundamental herbs of traditional Chinese medicine, has been characterized for its therapeutic activity whilst its molecular target has remained unknown. Febrifugine derivatives have been used to treat malaria, cancer, fibrosis, and inflammatory disease. We recently demo...
Autores principales: | Keller, Tracy L., Zocco, Davide, Sundrud, Mark S., Hendrick, Margaret, Edenius, Maja, Yum, Jina, Kim, Yeon-Jin, Lee, Hak-kyo, Cortese, Joseph F., Wirth, Dyann, Dignam, John David, Rao, Anjana, Yeo, Chang-Yeol, Mazitschek, Ralph, Whitman, Malcolm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281520/ https://www.ncbi.nlm.nih.gov/pubmed/22327401 http://dx.doi.org/10.1038/nchembio.790 |
Ejemplares similares
-
Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance
por: Tye, Mark A., et al.
Publicado: (2022) -
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
por: Kurata, Keiji, et al.
Publicado: (2023) -
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
por: Kurata, Keiji, et al.
Publicado: (2023) -
Microarray profiling reveals the integrated stress response is activated by halofuginone in mammary epithelial cells
por: Kamberov, Yana G, et al.
Publicado: (2011) -
Evolution of acceptor stem tRNA recognition by class II prolyl-tRNA synthetase
por: An, Songon, et al.
Publicado: (2008)